[Table/Fig-11]:
Study | Year | Method | % US | % ECA | % of revised Bethesda categories | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ASC-US | ASC-H | LSIL (+HPV) | HSIL | SCC | AGC | ADC | |||||
Sankara-narayanan et al.,[9] | 2004 | C | 3.8 | 17.02 | 8.8 | - | 6.2 | 1.8 | 0.22 | - | - |
Bal et al.,[10] | 2012 | C | 4.1 | 5 | 0.3 | - | 2.7 | 0.7 | 1.3 | - | - |
Altaf and Mufti [11] | 2012 | C + L | 0.85 | 17.3 | 9.3 | 0.8 | 2.7 | 0.9 | 0.06 | 3.38 | - |
Mulazim et al., [12] | 2012 | C | 1.8 | 10.2 | 1 | - | 4.6 | 2.2 | 1.4 | 0.4 | 0.6 |
Present | 2014 | C | 2.4 | 13.6 | 4.8 | - | 5.6 | 0.8 | 0.8 | 0.8 | 0.8 |
C (conventional), +L (liquid based cytology), US (unsatisfactory), ECA (epithelial cell abnormalities), ASC-US(atypical squamous cells of unknown origin), LSIL (low grade squamous intraepithelial lesion), +HPV (human papilloma virus), HSIL (high grade squamous intraepithelial lesion), SCC (squamous cell carcinoma), AGC (atypical glandular cells), ADC (adenocarcinoma)